- Home
- Publications
- Publication Search
- Publication Details
Title
Anti-platelet therapy: ADP receptor antagonists
Authors
Keywords
-
Journal
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
Volume 72, Issue 4, Pages 647-657
Publisher
Wiley
Online
2011-04-26
DOI
10.1111/j.1365-2125.2011.03999.x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Comparison of 2 point-of-care platelet function tests, VerifyNow Assay and Multiple Electrode Platelet Aggregometry, for predicting early clinical outcomes in patients undergoing percutaneous coronary intervention
- (2011) Young-Guk Ko et al. AMERICAN HEART JOURNAL
- Extracellular Ca2+ modulates ADP-evoked aggregation through altered agonist degradation: implications for conditions used to study P2Y receptor activation
- (2011) Sarah Jones et al. BRITISH JOURNAL OF HAEMATOLOGY
- Ticagrelor
- (2011) James J. Nawarskas et al. Cardiology in Review
- Pharmacokinetics and the antiplatelet effect of a new clopidogrel formulation, clopidogrel besylate, in healthy subjects
- (2011) J.-Y. Park et al. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
- Standard- vs High-Dose Clopidogrel Based on Platelet Function Testing After Percutaneous Coronary Intervention
- (2011) Matthew J. Price JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- An Initial Experiment With Personalized Antiplatelet Therapy
- (2011) Paul A. Gurbel JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- CYP2C19 and ABCB1 genes and individualized treatment with clopidogrel
- (2011) Bas JM Peters et al. PHARMACOGENOMICS
- P2Y12and EP3 antagonists promote the inhibitory effects of natural modulators of platelet aggregation that act via cAMP
- (2011) David Iyú et al. PLATELETS
- P2Y12 receptor in platelet activation
- (2011) Soochong Kim et al. PLATELETS
- Signaling During Platelet Adhesion and Activation
- (2010) Zhenyu Li et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Adenosine Derived From ADP Can Contribute to Inhibition of Platelet Aggregation in the Presence of a P2Y 12 Antagonist
- (2010) David Iyú et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Benzofuran-substituted urea derivatives as novel P2Y1 receptor antagonists
- (2010) Reema K. Thalji et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Pharmacokinetics, pharmacodynamics, tolerability and safety of single ascending doses of ticagrelor, a reversibly binding oral P2Y12 receptor antagonist, in healthy subjects
- (2010) Renli Teng et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Incidence of Dyspnea and Assessment of Cardiac and Pulmonary Function in Patients With Stable Coronary Artery Disease Receiving Ticagrelor, Clopidogrel, or Placebo in the ONSET/OFFSET Study
- (2010) Robert F. Storey et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Inhibitory Effects of Ticagrelor Compared With Clopidogrel on Platelet Function in Patients With Acute Coronary Syndromes
- (2010) Robert F. Storey et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial
- (2010) Shamir R Mehta et al. LANCET
- Effect of CYP2C19 and ABCB1 single nucleotide polymorphisms on outcomes of treatment with ticagrelor versus clopidogrel for acute coronary syndromes: a genetic substudy of the PLATO trial
- (2010) Lars Wallentin et al. LANCET
- Paraoxonase-1 is a major determinant of clopidogrel efficacy
- (2010) Heleen J Bouman et al. NATURE MEDICINE
- Individual variability in the disposition of and response to clopidogrel: Pharmacogenomics and beyond
- (2010) Hong-Guang Xie et al. PHARMACOLOGY & THERAPEUTICS
- The new INNOVANCE® PFA P2Y cartridge is sensitive to the detection of the P2Y12receptor inhibition
- (2010) Juergen Koessler et al. PLATELETS
- The P2X1ion channel in platelet function
- (2010) Hu Hu et al. PLATELETS
- Intra-individual variability in clopidogrel responsiveness in coronary artery disease patients under long term therapy
- (2010) Sébastien Arméro et al. PLATELETS
- Clopidogrel non-responsiveness and risk of cardiovascular morbidity
- (2010) Rossella Marcucci et al. THROMBOSIS AND HAEMOSTASIS
- Mode of action of P2Y12 antagonists as inhibitors of platelet function
- (2010) D. Iyú et al. THROMBOSIS AND HAEMOSTASIS
- Antagonists of the EP3Receptor for Prostaglandin E2Are Novel Antiplatelet Agents That Do Not Prolong Bleeding
- (2009) Jasbir Singh et al. ACS Chemical Biology
- Ticagrelor: The First Reversibly Binding Oral P2Y12Receptor Antagonist
- (2009) Steen Husted et al. Cardiovascular Therapeutics
- Intensifying Platelet Inhibition With Tirofiban in Poor Responders to Aspirin, Clopidogrel, or Both Agents Undergoing Elective Coronary Intervention
- (2009) Marco Valgimigli et al. CIRCULATION
- Bedside Evaluation of Thienopyridine Antiplatelet Therapy
- (2009) Matthew J. Price CIRCULATION
- Randomized Double-Blind Assessment of the ONSET and OFFSET of the Antiplatelet Effects of Ticagrelor Versus Clopidogrel in Patients With Stable Coronary Artery Disease
- (2009) Paul A. Gurbel et al. CIRCULATION
- Comparing the antiplatelet effect of clopidogrel hydrogensulfate and clopidogrel besylate: a crossover study
- (2009) Horst Neubauer et al. Clinical Research in Cardiology
- Bioequivalence and tolerability of two clopidogrel salt preparations, besylate and bisulfate: A randomized, open-label, crossover study in healthy Korean male subjects
- (2009) Sung-Doo Kim et al. CLINICAL THERAPEUTICS
- New P2Y12 antagonists
- (2009) Alan D Michelson CURRENT OPINION IN HEMATOLOGY
- P2Y12 inhibitors: differences in properties and mechanisms of action and potential consequences for clinical use
- (2009) L. Wallentin EUROPEAN HEART JOURNAL
- The P2Y12Antagonists, 2-Methylthioadenosine 5′-Monophosphate Triethylammonium Salt and Cangrelor (ARC69931MX), Can Inhibit Human Platelet Aggregation through a Gi-independent Increase in cAMP Levels
- (2009) Subhashini Srinivasan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Ticagrelor binds to human P2Y12independently from ADP but antagonizes ADP-induced receptor signaling and platelet aggregation
- (2009) J. J. J. VAN GIEZEN et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Limitations of current therapies to prevent thrombosis: a need for novel strategies
- (2009) Jean-Etienne Fabre et al. Molecular BioSystems
- Intravenous Platelet Blockade with Cangrelor during PCI
- (2009) Deepak L. Bhatt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
- (2009) Lars Wallentin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Platelet Inhibition with Cangrelor in Patients Undergoing PCI
- (2009) Robert A. Harrington et al. NEW ENGLAND JOURNAL OF MEDICINE
- Measurement of platelet P-selectin for remote testing of platelet function during treatment with clopidogrel and/or aspirin
- (2009) S. C. Fox et al. PLATELETS
- P2Y1 receptor antagonists as novel antithrombotic agents
- (2008) Jeffrey A. Pfefferkorn et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- The reversible P2Y12antagonist cangrelor influences the ability of the active metabolites of clopidogrel and prasugrel to produce irreversible inhibition of platelet function
- (2008) N. L. DOVLATOVA et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- DG-041 inhibits the EP3 prostanoid receptor—A new target for inhibition of platelet function in atherothrombotic disease
- (2008) Stan Heptinstall et al. PLATELETS
- Acyl derivatives of coenzyme A inhibit platelet function via antagonism at P2Y1and P2Y12receptors: A new finding that may influence the design of anti-thrombotic agents
- (2008) P. Manolopoulos et al. PLATELETS
- Role of P2Y receptor subtypes in platelet-derived microparticle generation
- (2007) Bryan et al. Frontiers in Bioscience-Landmark
- Transitioning patients from cangrelor to clopidogrel: Pharmacodynamic evidence of a competitive effect
- (2007) Steven R. Steinhubl et al. THROMBOSIS RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More